Synthetic retinoids (in cell modulation)
Abstract:
There are described novel compounds of formula I: (I) in which, in which A1, A2, A3, A4, R1 and R2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition; and methods related thereto.
Public/Granted literature
Information query
Patent Agency Ranking
0/0